Development Asset Lead, Senior Director
Full-timeSeniorNeurologyPhD
$274K - $377K/yr(estimated)
Description
<h2><b>About This Role</b></h2><p>The Senior Director, Development Asset Lead (DAL) is responsible for leading one or more preclinical or clinical-stage assets within Biogen’s development portfolio. This role provides strategic, cross-functional leadership to maximize asset value and ensure effective execution of the integrated asset plan (IAP). The DAL partners across research, development, and commercial functions to align scientific strategy, operational execution, and business considerations such as time, risk, and value. As leader of the asset team, the DAL drives development strategy, oversees progress toward key milestones, and represents the program within governance forums. This role reports to the <b>Head of Development Asset Leadership</b> and is responsible for guiding the most complex or late-stage assets, including programs approaching regulatory filing or major stage-gate decisions.</p><h2><b>What You’ll Do</b></h2><ul><li><p>Lead development and continuous refinement of the integrated asset plan to maximize value and efficient execution</p></li><li><p>Define asset strategy, goals, timelines, and risk mitigation plans in partnership with program management</p></li><li><p>Drive cross-functional alignment and accountability for delivery of integrated development plans</p></li><li><p>Represent the asset at portfolio governance forums and senior leadership discussions</p></li><li><p>Integrate scientific, regulatory, and commercial considerations into development strategy and decision-making</p></li><li><p>Partner with Research, Development Units, and functional leaders to support portfolio planning and asset prioritization</p></li><li><p>Ensure effective program execution through collaboration with program management and functional teams</p></li><li><p>Foster a high-performing, collaborative team culture across the asset team</p></li><li><p>Contribute to departmental communities of practice to share insights and identify program synergies</p></li></ul><h2><b>Who You Are</b></h2><p>You are a strategic and collaborative leader with deep drug development expertise and the ability to guide complex, cross-functional teams. You bring strong scientific insight and business acumen to navigate development decisions and drive programs toward successful outcomes.</p><h2><b>Required Skills</b></h2><ul><li><p>Bachelor’s degree required; advanced degree strongly preferred (MS, MD, PhD, PharmD, or MBA)</p></li><li><p>13+ years of experience in pharmaceutical or biotechnology drug development</p></li><li><p>Proven leadership of cross-functional teams delivering complex development programs</p></li><li><p>Deep understanding of clinical development strategy and integrated asset planning</p></li><li><p>Strong knowledge of Minimum and Target Product Profile (MPP/TPP) concepts</p></li><li><p>Experience with IND-enabling activities, clinical pharmacology, and safety considerations</p></li><li><p>Working knowledge of global regulatory requirements for drug development and registration</p></li><li><p>Ability to translate emerging scientific and clinical data into development strategy</p></li><li><p>Strong executive communication and stakeholder management skills</p></li><li><p>Demonstrated ability to lead within a matrixed organizational environment</p></li></ul><h2><b>Preferred Skills</b></h2><ul><li><p>Prior experience leading cross-functional development programs or portfolio assets</p></li><li><p>Experience preparing programs for major development milestones or regulatory filings</p></li><li><p>Therapeutic area expertise within neuroscience or related disciplines</p></li></ul><p style="text-align:inherit"><br /> </p>Job Level: Management<p style="text-align:left"><br /><b>Additional Information</b></p><p style="text-align:inherit"></p>The base compensation range for this role is: $274,000.00-$377,000.00<div><p style="text-align:left"><br /><span>Base salary offered is determined through an analytical approach utilizing a combination of factors including, but not limited to, relevant skills & experience, job location, and internal equity.</span></p><p style="text-align:inherit"></p><p style="text-align:left"><span>Regular employees are eligible to receive both short term and long-term incentives, including cash bonus and equity incentive opportunities, designed to reward recent achievements and recognize your future potential based on individual, business unit and company performance. </span></p><p style="text-align:inherit"></p><p style="text-align:left"><span>In addition to compensation, Biogen offers a full and highly competitive range of benefits designed to support our employees’ and their families <i>physical, financial, emotional,</i> and <i>social well-being</i>; including, but not limited to:</span></p><ul><li><span>Medical, Dental, Vision, & Life insurances</span></li><li><span>Fitness & Wellness programs including a fitness reimbursement </span></li><li><span>Short- and Long-Term Disability insurance</span></li><li><span>A minimum of 15 days of paid vacation and an additional end-of-year shutdown time off (Dec 26-Dec 31)</span></li><li><span>Up to 12 company paid holidays + 3 paid days off for Personal Significance </span></li><li><span>80 hours of sick time per calendar year</span></li><li><span>Paid Maternity and Parental Leave benefit </span></li><li><span>401(k) program participation with company matched contributions</span></li><li><span>Employee stock purchase plan </span></li><li><span>Tuition reimbursement of up to $10,000 per calendar year </span></li><li><span><span>Employee Resource Groups participation</span></span></li></ul><p style="text-align:inherit"></p></div><div><p style="text-align:left"><b>Why Biogen?</b></p><p style="text-align:left">We are a global team with a commitment to excellence, and a pioneering spirit. As a mid-sized biotechnology company, we provide the stability and resources of a well-established business while fostering an environment where individual contributions make a significant impact. Our team encompasses some of the most talented and passionate achievers who have unparalleled opportunities for learning, growth, and expanding their skills. Above all, we work together to deliver life-changing medicines, with every role playing a vital part in our mission. Caring Deeply. Achieving Excellence. Changing Lives.</p><p style="text-align:inherit"></p><p style="text-align:left">At Biogen, we are committed to building on our culture of inclusion and belonging that reflects the communities where we operate and the patients we serve. We know that diverse backgrounds, cultures, and perspectives make us a stronger and more innovative company, and we are focused on building teams where every employee feels empowered and inspired.<span> </span><a href="https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.biogen.com%2Fresponsibility%2Fdiversity-inclusion.html&data=05%7C01%7Cdennis.mercier%40biogen.com%7C67adaf5a6edd4324716208db0dcd2182%7C7b7466bbfe1d47a0b9438ded565c8e54%7C0%7C0%7C638118946897044815%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=p2vFGx6ZWK7lyBEL4wuNIQJcKSVRZD90VuJxcOkjX04%3D&reserved=0" target="_blank">Read on</a><span> </span>to learn more about our DE&I efforts.</p><p style="text-align:inherit"></p><p style="text-align:left">All qualified applicants will receive consideration for employment without regard to sex, gender identity or expression, sexual orientation, marital status, race, color, national origin, ancestry, ethnicity, religion, age, veteran status, disability, genetic information or any other basis protected by federal, state or local law. Biogen is an E-Verify Employer in the United States.</p></div>
Biogen
BIOTECHNOLOGY
Small Molecules, Biologics, Biosimilars, ASO
LocationCAMBRIDGE, MA
Employees7,500
Open Jobs268
NeuroscienceRare DiseasesImmunology
View Company ProfilePipeline
Psychometric Validation of Cognitive EndpointsN/A
TysabriN/A
Evaluation of Brain Atrophy in CIS Patients on AvonexN/A
natalizumabN/A
Multicenter Observational Study of Myotonic Dystrophy Type 1N/A